MedTech Company | AI & Robotics Hair Restoration Systems | 22 Patents
Business Description
100% YOY Growth | FDA Class 1 Devices | Proprietary Technology
WebsiteClosers® presents a leading Robotics and AI-assisted MedTech company specializing in advanced Hair Restoration Technology. Established in 2018, this company has rapidly emerged as a leader in the industry, leveraging cutting-edge AI, AR, and Robotics to revolutionize hair transplant procedures. The company’s mission is to enhance efficiency and affordability in the field, achieving remarkable market penetration and a robust reputation among practitioners and entrepreneurs alike.
This 7-year-old company operates within a $5.7 billion global market that’s projected to grow nearly sevenfold by 2032. This company stands as a true category leader. With more than 22 granted patents, FDA Class 1 (510k exempt) devices, and 80 – 85% gross margins, it has built a formidable foundation for scalable expansion across both the U.S. and international markets. Their systems are designed with modular hardware and self-diagnostic software, allowing for easy maintenance and seamless integration into clinical environments.
The company has demonstrated consistent performance with 100% year-over-year growth, supported by an average deal size of $110,000 and projected 2025 revenue exceeding $2 million. Their products, powered by artificial intelligence, augmented reality, and robotic automation, deliver superior speed and precision, drastically reducing procedure times while improving clinical outcomes.
Beyond product sales, the business has developed complementary revenue streams that strengthen long-term growth. Through specialized training and certification programs, as well as turnkey clinic models, it supports new practitioners in launching successful practices. These programs not only drive additional revenue but also create an ecosystem that keeps clients deeply connected to the brand.
Key Valuation Points
• 100% Year-over-Year Growth
• 22+ Granted Patents
• 80-85% Gross Margins
• $2M+ Projected Revenue in 2025
• $110k Avg. Deal Size
• FDA Class 1 (510k Exempt) Devices
• 80% Local Procurement
• Patented Proprietary Technology
• Modular, Self-Diagnostic Hardware
A key highlight for buyers is the founder’s willingness to remain involved post-acquisition, either as a consultant or through rolled equity. This continuity ensures a seamless transfer of technical expertise and product development oversight, giving buyers the advantage of scaling the company under the guidance of its original inventor. Operational efficiency is another standout feature of this business. With a lean team and high production capacity, the company is well-prepared to scale operations without substantial additional investment. This scalability presents an attractive proposition for potential buyers looking to expand their market reach and operational capabilities.
The company is supported by a robust intellectual property portfolio, underscoring its commitment to innovation and excellence. This, coupled with a streamlined logistics system and compliance with regulatory requirements, positions the brand as a compelling acquisition target in the medical device sector. The company is ready to expand into key international markets, including Canada, Mexico, Brazil, and the EU, while exploring subscription-based SaaS opportunities through its proprietary AI platform. These initiatives represent a clear path to recurring revenue and global brand visibility.
This company represents an exceptional opportunity for buyers seeking to invest in a proven, innovative player within the rapidly growing hair restoration market. Contact WebsiteClosers® today to learn more about this unique business opportunity.
WC 3832
This 7-year-old company operates within a $5.7 billion global market that’s projected to grow nearly sevenfold by 2032. This company stands as a true category leader. With more than 22 granted patents, FDA Class 1 (510k exempt) devices, and 80 – 85% gross margins, it has built a formidable foundation for scalable expansion across both the U.S. and international markets. Their systems are designed with modular hardware and self-diagnostic software, allowing for easy maintenance and seamless integration into clinical environments.
The company has demonstrated consistent performance with 100% year-over-year growth, supported by an average deal size of $110,000 and projected 2025 revenue exceeding $2 million. Their products, powered by artificial intelligence, augmented reality, and robotic automation, deliver superior speed and precision, drastically reducing procedure times while improving clinical outcomes.
Beyond product sales, the business has developed complementary revenue streams that strengthen long-term growth. Through specialized training and certification programs, as well as turnkey clinic models, it supports new practitioners in launching successful practices. These programs not only drive additional revenue but also create an ecosystem that keeps clients deeply connected to the brand.
Key Valuation Points
• 100% Year-over-Year Growth
• 22+ Granted Patents
• 80-85% Gross Margins
• $2M+ Projected Revenue in 2025
• $110k Avg. Deal Size
• FDA Class 1 (510k Exempt) Devices
• 80% Local Procurement
• Patented Proprietary Technology
• Modular, Self-Diagnostic Hardware
A key highlight for buyers is the founder’s willingness to remain involved post-acquisition, either as a consultant or through rolled equity. This continuity ensures a seamless transfer of technical expertise and product development oversight, giving buyers the advantage of scaling the company under the guidance of its original inventor. Operational efficiency is another standout feature of this business. With a lean team and high production capacity, the company is well-prepared to scale operations without substantial additional investment. This scalability presents an attractive proposition for potential buyers looking to expand their market reach and operational capabilities.
The company is supported by a robust intellectual property portfolio, underscoring its commitment to innovation and excellence. This, coupled with a streamlined logistics system and compliance with regulatory requirements, positions the brand as a compelling acquisition target in the medical device sector. The company is ready to expand into key international markets, including Canada, Mexico, Brazil, and the EU, while exploring subscription-based SaaS opportunities through its proprietary AI platform. These initiatives represent a clear path to recurring revenue and global brand visibility.
This company represents an exceptional opportunity for buyers seeking to invest in a proven, innovative player within the rapidly growing hair restoration market. Contact WebsiteClosers® today to learn more about this unique business opportunity.
WC 3832
About the Business
- Years in Operation
- 7
- Currently Relocatable
- Yes
Listing Info
- ID
- 2423999
- Listing Views
- 50
Listing ID: 2423999 The information on this listing has been provided by either the seller or a business broker representing the seller. BizQuest has no interest or stake in the sale of this business and has not verified any of the information and assumes no responsibility for its accuracy, veracity, or completeness. See our full Terms of Use. Learn how to avoid scams.
Businesses for SaleFlorida Businesses for SaleFlorida Technology Businesses for SaleFlorida Other Technology Businesses for Sale